MIGENTRA

With its founding partners headquartered in Berlin, Germany, and Cairo, Egypt, MiGenTra is uniquely positioned to reap the benefits of a solid foothold in the MEA region and a significant European customer base... Incorporated in 2021 by ProBioGen (internationally known CMDO) and Minapharm Pharmaceuticals (only gene-to-market biopharmaceutical company in Africa & the Middle East), MiGenTra fuses the scientific, manufacturing, and commercial expertise of its parent companies towards the end-to-end development and commercialization of high quality affordable biologic medicines in the field of Biosimilars, Cell- and Gene Therapies and Vaccines to serve the needs of patients across Africa and the Middle East. The company is based in Berlin, with management both in Berlin and Cairo... MiGenTra strives to establish equitable access to high-quality biologics at affordable prices for Egypt, the Middle East, and Africa (MEA) while simultaneously strengthening regional and local manufacturing..

Also known as: MiGenTra GmbH

Registration numbers: HRB 229485 B (W)

VAT numbers: DE344168246

Primary location: Berlin Germany